Novel Microdevices, Inc. awarded up to $13.8 million from CARB-X for the development of a rapid, point-of-care, molecular diagnostic platform for the detection of sexually transmitted diseases, including antibiotic-resistant infections by NovelDX | Apr 6, 2021 | News
Novel Microdevices Joins Baltimore’s LaunchPort™ Medtech Venture Center by NovelDX | Feb 26, 2021 | News
Startup Novel Microdevices Developing Rapid Point-of-Care MDx System for STIs by NovelDX | May 24, 2019 | News
These two Baltimore biotech hubs are partnering to help scientist-entrepreneurs by NovelDX | Mar 20, 2018 | News
Recent Comments